Phenoxybenzamine Hydrochloride Capsules — Class II drug recall D-0061-2023
Terminated recall by Par Formulations Private Limited, reported 2022-11-23, distributed nationwide. Failed Impurities/Degradation Specifications
| Recall number | D-0061-2023 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Par Formulations Private Limited, Chennai, N/A, India |
| Recall initiated | 2022-11-10 |
| Classified | 2022-11-15 |
| Reported by FDA | 2022-11-23 |
| Terminated | 2023-08-18 |
| Distributed | Nationwide (US) |
| Reason classes | specification failure |
| NDC | 49884-0038-01 |
| Lot numbers | 15429401 |
| Expiration dates | 2023-08 |
Product
Phenoxybenzamine Hydrochloride Capsules, USP 10mg, 100-count bottles, RX only Dist. by: Par Pharmaceutical Chestnut Ridge, NY 10977 U.S.A. Mfg. by: Par Forumulations Private Limited,9/215, Pudupakkam, Kelambakkam - 603 103. NDC 49884-038-01
Reason for recall
Failed Impurities/Degradation Specifications
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0061-2023. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.